DR.NOAH Biotech is the next-generation pharmaceutical company that seeks efficient new drug development based on big data analysis medicine and artificial intelligence technology. Based on the world's best drug forecasting technology, the company aims to develop the world's first treatment for rare genetic diseases. The new Orphan Drug Market is a growing market and an area of high investment value. There are more than 7,000 rare diseases, but more than 90 percent of them do not have proper drugs yet. It would take more than 500 years to develop the new drug at the current rate of development for the rare disease. DR.NOAH Biotech will be able to complete the prediction of orphan drug within 3 months by utilizing the technology to complete the development of the medication in a short time more efficiently than the conventional method.

Dr. Noah Biotech (닥터노아바이오텍)

Dr. Noah Biotech (닥터노아바이오텍)